Arthritis Ease Study
Knee Osteoarthritis, Chronic Pain, Kinesiophobia
About this trial
This is an interventional supportive care trial for Knee Osteoarthritis focused on measuring Heart Rate Variability, Biofeedback, Virtual Reality, Body awareness, Self regulation
Eligibility Criteria
Inclusion Criteria: English speaking adults Diagnosed osteoarthritis of the knee(s) smart phone access Pain scale rating of 4-10 on the numerical pain rating scale (0- 10) \ Pain duration of 3 months or greater Score of 15 or greater on the Tampa Scale of Kinesiophobia (fear of movement) scale Eligibility includes: Willingness to engage in the study for 8 weeks Being available for 1-3 phone calls for data collection at pre- and post-8-week intervention and at 4 weeks post-intervention conclusion Exclusion criteria: Self-report of: acute illness, Cancer HIV Systemic inflammatory disease (rheumatoid arthritis, lupus) History of neurologic disease, seizure disorder, Current or history of mental illness illness with hallucinations Motion sickness or vestibular disorders Acute or chronic respiratory disease Dysrhythmic heart disease Beta or calcium channel blocker medication use Monovision \\ Current use of Heart rate variability training activities will also be excluded
Sites / Locations
- Arizona State UniversityRecruiting
Arms of the Study
Arm 1
Experimental
Single Arm Study
All participants will receive access to the phone application with a virtual reality headset and heart rate variability Bluetooth ear sensor. Participants will be instructed to download a free phone app Elite Heart Rate Variability, login using study provided de-identified research email address, pair the Bluetooth ear sensor and record a five-minute resting heart rate variability reading at baseline and each time point of the study prior to beginning intervention. Participants will be asked to use the intervention phone application for 7-10 minute sessions twice daily 5 days a week for 8 weeks. For the first 8 weeks, participants will receive brief, daily texts encouraging participation in the smart phone application. During weeks 9 through 12, will receive relaxation reminders daily via text to determine if use is sustained past the intervention phase